HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hillhouse Capital Related

521.158

+1.1990.23%

Number of Gainers:24

Number of Losers:25

Number of Flat:6

PE:- -

High:527.577

Open:519.978

Low:519.978

Close:519.960

Volume:445.26M

Turnover:10.97B

Market Cap:3.11T

Float Cap:2.34T

Loading ...

Goldman Sachs Lowers Target Price for XTEP INT'L (01368) to HK$6.80, Maintains "Buy" Rating

UBS Lowers Target Price for CHINA TOWER (00788) to HKD 13.5, Maintains "Buy" Rating

Liang Qiang Approved as Chairman of China Orient

Tian Rui Approved as Director of Taiping Asset Management

HK Stocks in Action | ANTENGENE-B (06996) Surges Over 6% Following Latest Clinical Results of ATG-022

GTHT Maintains "Buy" Rating for XTEP INT'L (01368) with Target Price of HK$8.74

CMSC Maintains "Buy" Rating for XTEP INT'L with a Target Price of HK$7.70

Hong Kong Stocks Update: AK MEDICAL (01789) Surges Over 9% Amid Accelerated Import Substitution and High-End Hospital Coverage

CMSC Maintains "Buy" Rating for FUYAO GLASS (03606) with Target Price of HKD 86

Shenwan Hongyuan Reiterates "Buy" Rating for XTEP INT'L (01368) as DTC Transformation Progresses Steadily

Hong Kong Stock Movement | JD Health (06618) Rises Over 5% in Early Trading as Institutions Predict Increased Drug Sales Contribution Will Benefit Overall Gross Margin

Haitong International: Hansoh Pharma (03692) Licenses CDH17ADC to Roche for Over $1.5 Billion

Guosheng Securities Maintains "Buy" Rating on XTEP International (01368), Stable Growth in Main Brand Revenue

Hong Kong Stock Buyback Statistics | October 20

Antengene Reports Promising ATG-022 Phase I/II Results in Gastric Cancer at ESMO 2025

Hansoh Pharma Reports Promising Phase 2 Results for HS-20093 in Relapsed or Refractory Sarcomas

Hansoh Pharma Reports Positive Phase 2 Results for HS-20089 in Platinum-Resistant Ovarian Cancer

Mitsubishi UFJ Financial Group, Inc. Reduces Stake in FUYAO GLASS by 577,200 Shares at Approximately HKD 73.84 per Share

JXR Executive Director Dong Yang Acquires 500,000 Shares at HKD 2.56 Each

Hong Kong Stock Connect Fund Flow Statistics (T+2) | October 20

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1583/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"Hillhouse Capital Related","latestPrice":521.1584,"timestamp":1761034088874,"preClose":519.9595,"halted":0,"volume":445261892,"delay":0,"changeRate":0.002306,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":1.198914,"latestTime":"10-21 16:00:00","open":519.97797,"high":527.5774,"low":519.97797,"amount":10971179538.4,"amplitude":0.014615,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1761096600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1761010200000,1761019200000],[1761022800000,1761033600000]],"pbRate":2.476747,"peRate":23.036044,"turnoverRate":0.003073,"increases":26,"decrements":23,"flats":5,"marketCap":3107224730624,"floatMarketCap":2335381729280},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":527.5774,"amplitude":0.014615,"preClose":519.9595,"low":519.97797,"pbRate":"2.476747","latestPrice":521.1584,"volume":445261892,"delay":0,"open":519.97797,"prevYearClose":446.93042,"prevWeekClose":511.616,"prevMonthClose":552.537,"prevQuarterClose":552.537,"fiveDayClose":513.904,"twentyDayClose":552.193,"sixtyDayClose":548.862,"secType":"PLATE","market":"HK","turnoverRate":0.003073,"peRate":23.036044,"marketCap":3107224730624,"floatMarketCap":2335381729280,"timestamp":1761034088874,"nameCN":"Hillhouse Capital Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":24,"down":25,"flat":6},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1129173785","title":"Goldman Sachs Lowers Target Price for XTEP INT'L (01368) to HK$6.80, Maintains \"Buy\" Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1129173785","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129173785?lang=en_us&edition=fundamental","pubTime":"2025-10-20 15:50","pubTimestamp":1760946609,"startTime":"0","endTime":"0","summary":"Goldman Sachs has released a report indicating that XTEP INT'L (01368) announced its operational performance for the third quarter of 2025. The retail sales of its core brand XTEP grew year-on-year...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1168","LU0702159699.USD","LU0702159343.USD","LU1166156734.SGD","BK1502","BK1583","BK1512","01368"],"gpt_icon":0},{"id":"1165212733","title":"UBS Lowers Target Price for CHINA TOWER (00788) to HKD 13.5, Maintains \"Buy\" Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1165212733","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165212733?lang=en_us&edition=fundamental","pubTime":"2025-10-20 14:30","pubTimestamp":1760941822,"startTime":"0","endTime":"0","summary":"According to the latest report from UBS, CHINA TOWER (00788) recorded year-on-year growth in Q3 revenue, EBITDA, and net profit of 2.1%, 0.4%, and 4.5%, respectively, which fell short of market...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BG0RBZ43.SGD","BK1133","LU0823413660.USD","BK1529","IE00BHRH8C09.USD","LU0823413587.USD","BK1506","IE00BHRH8D16.HKD","BK1589","00788","BK1521","BK1583"],"gpt_icon":0},{"id":"1110783847","title":"Liang Qiang Approved as Chairman of China Orient","url":"https://stock-news.laohu8.com/highlight/detail?id=1110783847","media":"Deep News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110783847?lang=en_us&edition=fundamental","pubTime":"2025-10-20 14:21","pubTimestamp":1760941269,"startTime":"0","endTime":"0","summary":"On October 20, it was reported that the National Financial Regulatory Administration recently issued a response regarding Liang Qiang's qualifications for the position of Chairman of China Orient Asset Management Co., Ltd., officially approving his qualifications for this role.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1258","BK1542","SINA","BK1229","BK1583","09983"],"gpt_icon":0},{"id":"1197111744","title":"Tian Rui Approved as Director of Taiping Asset Management","url":"https://stock-news.laohu8.com/highlight/detail?id=1197111744","media":"Deep News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197111744?lang=en_us&edition=fundamental","pubTime":"2025-10-20 14:20","pubTimestamp":1760941259,"startTime":"0","endTime":"0","summary":"On October 20, financial news reported that the National Financial Regulatory Administration recently issued a response regarding Tian Rui's qualification to serve as a director of Taiping Pacific Asset Management Co., Ltd., approving her appointment to this position.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1229","BK1542","BK1258","SINA","09983"],"gpt_icon":0},{"id":"1167891951","title":"HK Stocks in Action | ANTENGENE-B (06996) Surges Over 6% Following Latest Clinical Results of ATG-022","url":"https://stock-news.laohu8.com/highlight/detail?id=1167891951","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167891951?lang=en_us&edition=fundamental","pubTime":"2025-10-20 14:12","pubTimestamp":1760940747,"startTime":"0","endTime":"0","summary":"According to reports, ANTENGENE-B (06996) saw its shares rise over 6%, currently at a 6.16% increase, trading at HKD 5.17 with a turnover of HKD 12.1859 million. On October 20, ANTENGENE announced...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","06996","BK1191","BK1583"],"gpt_icon":0},{"id":"1104618152","title":"GTHT Maintains \"Buy\" Rating for XTEP INT'L (01368) with Target Price of HK$8.74","url":"https://stock-news.laohu8.com/highlight/detail?id=1104618152","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104618152?lang=en_us&edition=fundamental","pubTime":"2025-10-20 14:10","pubTimestamp":1760940654,"startTime":"0","endTime":"0","summary":"According to reports from GTHT, they have maintained their profit forecasts for XTEP INT'L (01368) at RMB 1.37 billion, RMB 1.49 billion, and RMB 1.61 billion for 2025-2027. Given that the company is...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1564","LU0702159343.USD","BK1583","02611","BK1512","BK1502","BK1147","01368","LU1166156734.SGD","BK1168","LU0702159699.USD"],"gpt_icon":0},{"id":"1188762833","title":"CMSC Maintains \"Buy\" Rating for XTEP INT'L with a Target Price of HK$7.70","url":"https://stock-news.laohu8.com/highlight/detail?id=1188762833","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188762833?lang=en_us&edition=fundamental","pubTime":"2025-10-20 12:51","pubTimestamp":1760935863,"startTime":"0","endTime":"0","summary":"CMSC published a research report maintaining its \"Buy\" rating for XTEP INT'L (01368), reaffirming the company's guidance for full-year results in 2025 and anticipating strong growth in the fourth...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1564","BK1583","BK1502","06099","LU0702159699.USD","01368","LU1166156734.SGD","LU0702159343.USD","BK1168","BK1147","BK1512"],"gpt_icon":0},{"id":"1131918631","title":"Hong Kong Stocks Update: AK MEDICAL (01789) Surges Over 9% Amid Accelerated Import Substitution and High-End Hospital Coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=1131918631","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131918631?lang=en_us&edition=fundamental","pubTime":"2025-10-20 11:44","pubTimestamp":1760931865,"startTime":"0","endTime":"0","summary":"According to reports, AK MEDICAL (01789) saw its shares rise over 9% this morning, currently increasing by 8.73% to HKD 5.98, with a transaction volume of HKD 74.485 million. CITIC Construction...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1617","BK1583","01789","BK1100","BK1585"],"gpt_icon":0},{"id":"1171242736","title":"CMSC Maintains \"Buy\" Rating for FUYAO GLASS (03606) with Target Price of HKD 86","url":"https://stock-news.laohu8.com/highlight/detail?id=1171242736","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171242736?lang=en_us&edition=fundamental","pubTime":"2025-10-20 11:00","pubTimestamp":1760929222,"startTime":"0","endTime":"0","summary":"CMSC Hong Kong has released a research report stating that FUYAO GLASS (03606) possesses long-term growth potential for auto glass ASP, with new business ventures such as aluminum trim enhancing its...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516422440.USD","600660","BK0188","BK0028","IE0034224299.USD","03606","LU0502904849.HKD","SGXZ49509284.SGD","LU0072462343.USD","LU0572944931.SGD","BK1594","LU1655091616.SGD","LU1048588211.SGD","LU1064130708.USD","BK0183","LU2362540622.SGD","LU1064131003.USD","LU1820825898.SGD","LU0455707207.USD","BK1509","BK0235","BK0196","LU1785774172.SGD","LU2148510915.USD","BK1144","BK1564","BK1147","LU0327786744.USD","BK0015","06099","LU0516423091.SGD","LU0516423174.USD","LU2362541273.HKD","LU0051755006.USD","LU0516422366.SGD","LU1146622755.USD","LU2213484517.USD","LU0972618739.USD","LU0269904917.USD","LU0516422952.EUR","BK1554","LU2242644610.SGD","LU0456827905.SGD","IE0008368742.USD","IE0008369823.USD","LU0828238088.HKD","LU2362541513.USD","SGXZ81163826.USD","LU0509642566.USD","IE00B031HY20.USD","BK1583","BK0187","BK0175"],"gpt_icon":0},{"id":"1143224581","title":"Shenwan Hongyuan Reiterates \"Buy\" Rating for XTEP INT'L (01368) as DTC Transformation Progresses Steadily","url":"https://stock-news.laohu8.com/highlight/detail?id=1143224581","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143224581?lang=en_us&edition=fundamental","pubTime":"2025-10-20 10:32","pubTimestamp":1760927540,"startTime":"0","endTime":"0","summary":"According to Shenwan Hongyuan Group Co., Ltd., XTEP INT'L (01368) is continuously optimizing its multi-brand matrix. In 2024, it plans to divest its fashion sports brand to concentrate on its core...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0702159699.USD","000166","BK1583","BK0188","BK1502","BK1168","LU0702159343.USD","BK0028","LU1166156734.SGD","BK0276","01368","BK0183","BK1512","BK0012"],"gpt_icon":0},{"id":"1155662505","title":"Hong Kong Stock Movement | JD Health (06618) Rises Over 5% in Early Trading as Institutions Predict Increased Drug Sales Contribution Will Benefit Overall Gross Margin","url":"https://stock-news.laohu8.com/highlight/detail?id=1155662505","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155662505?lang=en_us&edition=fundamental","pubTime":"2025-10-20 10:18","pubTimestamp":1760926695,"startTime":"0","endTime":"0","summary":"JD Health (06618) experienced a surge of over 5% in early trading, and as of the time of writing, it is up 3.95%, priced at HKD 63.15, with a transaction volume of HKD 80.9976 million. Bank of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["86618","LU0051755006.USD","BK1589","SGXZ86797644.SGD","BK1583","LU0456827905.SGD","BK1591","BK1515","06618","BK1247","BK1142","BK1615","SGXZ62798434.SGD","BK1571"],"gpt_icon":0},{"id":"1144025723","title":"Haitong International: Hansoh Pharma (03692) Licenses CDH17ADC to Roche for Over $1.5 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1144025723","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144025723?lang=en_us&edition=fundamental","pubTime":"2025-10-20 10:08","pubTimestamp":1760926096,"startTime":"0","endTime":"0","summary":"Haitong International has reported that Hansoh Pharma (03692) has entered into a licensing agreement with Roche for HS-20110 (CDH17ADC). Under this agreement, Hansoh Pharma will receive an upfront...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","03692","BK1589"],"gpt_icon":0},{"id":"1159426703","title":"Guosheng Securities Maintains \"Buy\" Rating on XTEP International (01368), Stable Growth in Main Brand Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=1159426703","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159426703?lang=en_us&edition=fundamental","pubTime":"2025-10-20 09:36","pubTimestamp":1760924193,"startTime":"0","endTime":"0","summary":"According to reports, Guosheng Securities has published a research report stating that XTEP International (01368), a leading sportswear company in China, holds a significant advantage in the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01368","LU0702159699.USD","LU0702159343.USD","LU1166156734.SGD","BK1512","161027","BK1168","BK1583","BK1502"],"gpt_icon":0},{"id":"1134025124","title":"Hong Kong Stock Buyback Statistics | October 20","url":"https://stock-news.laohu8.com/highlight/detail?id=1134025124","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134025124?lang=en_us&edition=fundamental","pubTime":"2025-10-20 09:12","pubTimestamp":1760922743,"startTime":"0","endTime":"0","summary":"According to reports, on October 17, 2025, several companies including 中国恒有源集团 (CHYY GP), 方正控股 (FOUNDER HOLD), 摩比发展 (MOBI DEV), 天福 (TENFU), 心玮医疗-B (HEARTCARE-B), VITASOY INT'L (VITASOY INT'L), 首佳科技...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1167","LU0370786039.SGD","LU0348814723.USD","BK1128","LU0417516902.SGD","LU0456827905.SGD","LU2097828557.USD","LU0823426480.USD","LU1224709979.USD","LU2087589342.USD","IE0009570106.USD","IE00B29SXG58.USD","BK1521","BK1504","LU0164872284.USD","LU2279701549.SGD","08188","BK1506","IE00B3M56506.USD","LU0051755006.USD","06098","BK1202","BK1553","BK1583","LU0173614495.USD","LU1102505929.USD","BK1160","LU0348827113.USD","LU1328277881.USD","SG9999011746.SGD","LU0106959298.USD","BK1597","LU0254981946.USD","SG9999001093.SGD","LU0605514214.HKD","BK1130","BK1225","LU0052750758.USD","LU0164880469.USD","LU0244354667.USD","BK1575","LU0359201612.USD","LU0235996351.USD","BK1500","BK1600","02678","LU0210526637.USD","SG9999014674.SGD","LU1023057109.AUD","BK1613","LU0327786744.USD","LU0593848301.USD","LU0572944931.SGD","BK1502","BK1615","LU0326950275.SGD","09979","LU0228367735.SGD","LU2257852520.SGD","BK1209","00460","BK1518","LU0054450605.USD","LU0359201885.HKD","LU0314109678.HKD","LU0797268264.HKD","01328","BK1519","IE0031814852.USD","LU1981816686.USD","BK1549","81810","LU2778985437.USD","LU0163747925.USD","LU2399975544.HKD","LU0029875118.USD","LU1880383440.USD","LU0348825331.USD","02121","BK1599","IE00B97KM107.HKD","02498","BK1574","LU0675040207.SGD","LU0499858438.USD","03337","LU0072462343.USD","01681","IE00B031HY20.USD","BK1097","BK1589","LU0588546209.SGD","LU0471298777.SGD","LU0594300419.USD","02190","BK1610","LU0164865239.USD","LU0231483743.USD","LU1102505762.USD","01586","01167","LU0039217434.USD","BK1588","IE0008368742.USD","LU0251143458.SGD","LU0320764755.SGD","02423","LU0348816934.USD","LU1481107354.HKD","LU1961090484.USD","LU1808992512.USD","BK1237","BK1607","LU0611395673.USD","LU2476274720.SGD","LU0348788117.USD","LU0463099449.HKD","LU1956131251.USD","LU0651946864.USD","BK1229","BK1515","SG9999002463.SGD","IE0032431581.USD","BK1606","09959","IE0034224299.USD","IE00B067MR52.USD","LU0307460666.USD","LU0823397285.USD","LU2226246903.HKD","LU0287142896.SGD","LU1813983027.USD","BK1585","01986","BK1148","LU0084288322.USD","HK0000320223.HKD","BK1618","LU0823413660.USD","LU0259732245.USD","02057","LU1770036033.HKD","LU2152927971.USD","BK1215","BK1233","LU0228659784.USD","LU0823038988.USD","02299","BK1165","06868","BK1604","LU0320764599.SGD","LU1105468828.SGD","LU2097828631.EUR","BK1151","LU2097828805.USD","BK1189","LU0128522157.USD","09987","LU0634319403.HKD","SG9999003461.SGD","00777","IE0008369823.USD","LU0540923850.HKD","LU0737861699.HKD","02018","LU0214875030.USD","LU1188198961.HKD","01672","00732","LU1720050803.USD","BK1191","LU1051768304.USD","LU0918141705.HKD","00947","LU1868837565.USD","08128","LU0385154629.USD","LU1719994722.HKD","LU0345776255.USD","02319","LU0117841782.USD","LU0315179316.USD","LU0456846285.SGD","LU0871576103.HKD","HK0000320264.USD","BK1516","LU0531971595.HKD","BK1117","LU0823426308.USD","LU1868838027.USD","02273","LU0169518387.USD","BK1219","BK1161","BK1587","LU0441854154.USD","06609","HK0000306685.HKD","BK1179","BK1100","BK1526","LU0561508036.HKD","00685","HK0000306701.USD","LU0531970944.HKD","LU1439103000.SGD","LU0149721374.USD","LU0594300179.USD","09922","BK1158","LU0708995583.HKD","LU1515016050.SGD","SG9999006597.SGD","01810","LU1282648689.USD","00909","BK1170","LU0700851271.USD","LU1769817096.USD","HXXD.SI","LU1769817179.HKD","LU0672654166.SGD","02142","LU1880383366.USD","LU2045819591.USD","LU0918141887.USD","LU1303224171.USD","LU2097828474.EUR","BK1541","BK1149","02158","09669","BK1619","BK1531","BK1608","BK1193","IE00B0169L03.USD","LU0359202008.SGD","LU1323998911.USD","BK1104","BK1617","LU0143863198.USD","02120","LU0823397103.USD","LU0650527681.SGD","BK1523","BK1591","LU0048580855.USD","LU1770034418.SGD","IE00B031J352.USD","BK1258","02306","LU0449509016.USD","LU1251922891.USD","LU0143863784.USD","LU0348735423.USD","LU1794554557.SGD","00103","LU0345775950.USD","XIACY","LU2476274308.USD","LU0823039010.USD","LU0211977185.USD","LU0328353924.USD","LU0449515922.USD","LU2125910500.SGD","BK1593","MIUmain","LU0499858602.USD","01358","BK1109","LU2097828714.EUR","LU0823041008.USD","LU1048588211.SGD","BK1542","LU2039709279.SGD","BK1156","IE0032834883.USD","LU0543330483.HKD","SG9999002828.SGD","BK1129","00418","LU0417516738.SGD","00345","LU0823413587.USD","02373"],"gpt_icon":1},{"id":"2576000644","title":"Antengene Reports Promising ATG-022 Phase I/II Results in Gastric Cancer at ESMO 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2576000644","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576000644?lang=en_us&edition=fundamental","pubTime":"2025-10-20 09:00","pubTimestamp":1760922025,"startTime":"0","endTime":"0","summary":"Antengene Corporation Ltd. has announced new clinical data from the ongoing Phase I/II CLINCH study of ATG-022, a Claudin 18.2 antibody-drug conjugate , in patients with advanced gastric and gastroesophageal junction cancer. The results were presented in a poster session at the European Society for Medical Oncology Congress 2025  in Berlin. The study demonstrated efficacy across all CLDN18.2 expression levels, with three complete responses observed across different dose cohorts, including those with low or ultra-low CLDN18.2 expression. Safety data from the 2.4 mg/kg cohort indicated a favorable profile, with the lower 1.8 mg/kg cohort showing even better tolerability. ATG-022 has received two Orphan Drug designations from the U.S. FDA and Breakthrough Therapy Designation from China's NMPA for specific gastric cancer indications. Dose expansion studies are ongoing in China and Australia, with preparations underway for combination therapy trials.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nNDL8yfGk1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996","BK1583","BK1574","BK1191"],"gpt_icon":0},{"id":"2576007101","title":"Hansoh Pharma Reports Promising Phase 2 Results for HS-20093 in Relapsed or Refractory Sarcomas","url":"https://stock-news.laohu8.com/highlight/detail?id=2576007101","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576007101?lang=en_us&edition=fundamental","pubTime":"2025-10-20 08:35","pubTimestamp":1760920554,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group Co., Ltd. has announced the presentation of phase 2 clinical trial results for HS-20093, a B7-H3-targeted antibody-drug conjugate , in patients with relapsed or refractory (R/R) sarcomas. The data were presented at the ESMO 2025 Annual Meeting in Berlin on October 19, 2025. In the study, HS-20093 administered at 12 mg/kg every three weeks demonstrated a higher confirmed objective response rate and disease control rate in R/R osteosarcoma patients compared to the 8 mg/kg group. The 12 mg/kg group showed a confirmed objective response rate of 20.0% and a disease control rate of 86.7%, with a median progression-free survival of 8.4 months and a 15-month overall survival rate of 85.7%. In patients with soft tissue sarcoma , the confirmed objective response rate was 23.1% and the disease control rate was 92.3%, with a median progression-free survival of 9.4 months and median overall survival of 22.6 months. The safety profile was deemed manageable, with no new sa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nNDL7gbp5W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","BK1583","BK1191","BK1589"],"gpt_icon":0},{"id":"2576019002","title":"Hansoh Pharma Reports Positive Phase 2 Results for HS-20089 in Platinum-Resistant Ovarian Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2576019002","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576019002?lang=en_us&edition=fundamental","pubTime":"2025-10-20 08:17","pubTimestamp":1760919442,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group Co., Ltd. has announced positive phase 2 clinical trial results for HS-20089, a B7-H4-targeted antibody-drug conjugate , in patients with platinum-resistant ovarian cancer . The findings were presented in a poster session at the European Society for Medical Oncology  2025 Annual Meeting and will be featured in an oral presentation at the IGCS 2025 Annual Global Meeting in Cape Town, South Africa. HS-20089  demonstrated a confirmed objective response rate  of 48.5%, a duration of response  of 6.8 months, a median progression-free survival  of 6.4 months, and a median overall survival  of 14.6 months at a dose of 4.8 mg/kg. The safety profile was manageable, consistent with phase 1 data, and no new safety signals were observed. The phase 2 study included heavily pretreated PROC patients regardless of tumor B7-H4 expression. A phase 3 study of HS-20089 is currently ongoing .","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nNDLwP66y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1583","BK1589","03692"],"gpt_icon":0},{"id":"1146949970","title":"Mitsubishi UFJ Financial Group, Inc. Reduces Stake in FUYAO GLASS by 577,200 Shares at Approximately HKD 73.84 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1146949970","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146949970?lang=en_us&edition=fundamental","pubTime":"2025-10-20 07:50","pubTimestamp":1760917817,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on October 15, Mitsubishi UFJ Financial Group, Inc. divested 577,200 shares of FUYAO GLASS (03606) at a price of HKD 73.8368 per share,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1554","BK0175","LU0269904917.USD","LU0516423091.SGD","LU1048588211.SGD","LU1064131003.USD","LU1655091616.SGD","600660","LU0502904849.HKD","LU0516422440.USD","BK1144","LU2362541513.USD","LU0327786744.USD","BK0028","BK0235","LU2148510915.USD","LU0456827905.SGD","MBFJF","LU0509642566.USD","BK0188","BK1509","LU1820825898.SGD","LU0455707207.USD","LU0572944931.SGD","LU2242644610.SGD","LU2213484517.USD","LU2362540622.SGD","IE0008368742.USD","BK0015","IE00B031HY20.USD","LU2362541273.HKD","BK0196","LU0972618739.USD","BK1594","BK1583","BK0187","LU0051755006.USD","03606","LU0072462343.USD","LU1785774172.SGD","LU0828238088.HKD","IE0008369823.USD","LU1064130708.USD","LU0516422366.SGD","LU0516422952.EUR","LU1146622755.USD","SGXZ49509284.SGD","LU0516423174.USD","IE0034224299.USD","BK4207","BK0183","SGXZ81163826.USD"],"gpt_icon":0},{"id":"1106779621","title":"JXR Executive Director Dong Yang Acquires 500,000 Shares at HKD 2.56 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1106779621","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106779621?lang=en_us&edition=fundamental","pubTime":"2025-10-20 07:41","pubTimestamp":1760917262,"startTime":"0","endTime":"0","summary":"According to the latest information from the Hong Kong Stock Exchange, on October 15, Executive Director Dong Yang purchased 500,000 shares of JXR (01951) at a price of HKD 2.56 per share, totaling...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1597","BK1219","BK1583","01951"],"gpt_icon":0},{"id":"1193173652","title":"Hong Kong Stock Connect Fund Flow Statistics (T+2) | October 20","url":"https://stock-news.laohu8.com/highlight/detail?id=1193173652","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193173652?lang=en_us&edition=fundamental","pubTime":"2025-10-20 07:32","pubTimestamp":1760916750,"startTime":"0","endTime":"0","summary":"According to data from Zhichun Finance App, for October 15, the top three stocks with net inflows from southbound funds were DUALITYBIO-B (09606) with a net inflow of 882 million, BABA-W (09988) with...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0072913022.USD","LU0329678170.USD","LU0106252389.USD","LU0831103253.SGD","BK1591","LU1504937902.USD","LU0819123356.HKD","00220","LU0210527791.USD","LU0502904849.HKD","LU1861219969.SGD","LU1688375341.USD","LU2125910500.SGD","LU0878004406.USD","LU0588545490.SGD","LU1282651121.HKD","SG9999010078.USD","03360","LU0611395673.USD","LU0307460666.USD","LU0823397285.USD","BK1221","LU0051755006.USD","LU1769817179.HKD","BK1211","LU0516422366.SGD","LU1813983027.USD","LU1880383440.USD","LU2226246903.HKD","BK1526","LU0348766576.USD","LU0348783233.USD","LU1868837565.USD","LU0577902454.USD","IE00BQJZWZ67.USD","LU0588546209.SGD","LU1831875114.USD","LU2039709279.SGD","BK1163","LU0029875118.USD","LU0868486357.SGD","LU1023057109.AUD","LU0594300419.USD","LU0784639295.USD","LU0821914370.USD","00688","LU0823413660.USD","01858","BK1550","EVS.SI","BK1119","SG9999006514.SGD","LU0348784397.USD","01908","BK1589","BK1227","SG9999006597.SGD","HK0000320264.USD","LU0048597586.USD","LU0823426480.USD","IE00B5MMRT66.SGD","LU0608807433.USD","LU1808992512.USD","BK1557","00384","IE00B0169L03.USD","LU1102505929.USD","LU1807302812.USD","LU0577902371.SGD","LU0469268626.HKD","SG9999012710.SGD","LU1956131251.USD","LU0823039010.USD","LU1008478684.HKD","LU0417516738.SGD","LU0117844026.USD","LU0128522744.USD","LU0169518387.USD","LU0516423091.SGD","LU0164939612.USD","LU0417516571.SGD","LU0149534421.HKD","LU0605514214.HKD","LU1152091754.HKD","LU0572939691.SGD","LU1044876610.USD","01108","LU0348788117.USD","LU0293314216.USD","LU0651947912.USD","IE00BPRC5H50.USD","LU0620787316.HKD","IE00B0169N27.USD","SG9999012736.USD","LU0633140727.USD","LU0320764755.SGD","LU1548497426.USD","02357","LU1242518857.USD","LU0871576103.HKD","LU0541501648.USD","HK0000320223.HKD","LU0047713382.USD","01378","LU0231483743.USD","LU0823040885.USD","LU0456846285.SGD","09988","LU0543330483.HKD","LU0979878070.USD","LU0348827113.USD","BK1585","BK1175","BK1186","LU1224709979.USD","LU1044875133.USD","06181","LU1064130708.USD","00175","LU1196710864.SGD","LU0228367735.SGD","LU0878005551.USD","LU0143863784.USD","LU0856984785.SGD","LU2328871848.SGD","LU0700851271.USD","02837","LU0501845795.SGD","PNGAY","LU2360107325.USD","BK1096","LU1048588211.SGD","LU0266512473.USD","LU2153592121.USD","LU0052750758.USD","LU1242518931.SGD","LU1235295612.USD","LU1720050803.USD","LU0516423174.USD","LU1051769294.HKD","IE0003895053.USD","03968","HK0000306701.USD","LU1115378108.SGD","LU0320764599.SGD","LU0370786039.SGD","LU0441854154.USD","BK1588","LU0269904917.USD","LU0509642566.USD","IE00BMPRXR70.SGD","BK1586","82318","LU0328353924.USD","LU0797268264.HKD","LU0197773160.USD","IE0008368304.USD","LU0259732245.USD","02039","LU1515016050.SGD","LU0264606111.USD","IE0031814852.USD","LU0577902611.USD","LU1861214812.USD","80175","LU1769817096.USD","BK1604","IE00BVYPNQ40.USD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","LU2357305700.SGD","LU0762541174.USD","LU1960683339.HKD","PAImain","LU0149721374.USD","LU0132412106.USD","LU1770034418.SGD","02005","BK1615","BK1500","LU1282648689.USD","BK1183","BK1608","LU0140636845.USD","METmain","LU0594300179.USD","BK1610","LU0828237510.HKD","LU1251922891.USD","LU2097828631.EUR","BK1100","LU0127658192.USD","IE00B543WZ88.USD","LU0831093199.SGD","LU2449936058.SGD","BK1549","LU2348774022.SGD","03121","LU1064131003.USD","LU0326950275.SGD","LU0396098781.USD","LU1642822792.SGD","BK1142","SG9999012728.SGD","BK1249","BK1560","LU1282649067.USD","BK1501","02899","LU0348783662.USD","BK1240","LU0456827905.SGD","IE00B3M56506.USD","LU1328615791.USD","LU0650527681.SGD","SG9999014674.SGD","LU1794554557.SGD","09606","BK1575","LU1105468828.SGD","LU0384037296.USD","LU2476274720.SGD","BK1594","LU1568876335.HKD","SG9999002828.SGD","LU1770036033.HKD","LU0320764243.SGD","LU0067412154.USD","LU0589944569.HKD","02628","LU0499858602.USD","LU1568876251.USD","BK1563","LU0865486749.SGD","LU1719994722.HKD","BK1517","LU0417516902.SGD","LU1675838814.USD","LU0634319403.HKD","LU0117841782.USD","LU0648948544.HKD","01024","LU0228659784.USD","BK1149","LU0791590937.USD","LU0348825331.USD","LU1720051108.HKD","LU0196878994.USD","LU1734074674.USD","LU1282651048.USD","02800","LU2476274308.USD","HMTD.SI","LU0823413587.USD","LU0862451837.USD","LU1188198961.HKD","LU0640798160.USD","LU0143863198.USD","LU0675040207.SGD","LU2257852520.SGD","LU0918141887.USD","LU0828238088.HKD","03033","IE00BF5LJ272.USD","LU0348735423.USD","LU0499858438.USD","LU0164872284.USD","LU0455707207.USD","LU1303224171.USD","LU2399975544.HKD","SGXZ90724238.SGD","BK1224","LU0543330566.HKD","LU0651946864.USD","LU0049853897.USD","LU1211504680.USD","00856","LU0572940350.SGD","LU0345780521.USD","LU0823397103.USD","BK1539","BK1566","LU0261950983.USD","LU0737861772.HKD","LU0873338254.USD","LU1328277881.USD","LU0348814723.USD","LU0488056044.USD","LU0828237940.HKD","LU0593848301.USD","LU1961090484.USD","LU1051768304.USD","06869","LU0205439572.USD","MCHmain","BK1198","LU1439103000.SGD","LU0229945570.USD","LU0039217434.USD","KSTmain","LU0633140560.USD","BK1544","LU2097828714.EUR","BK1161","02318","SG9999002463.SGD","HBBD.SI","LU0173614495.USD","LU1981816686.USD","LU2152927971.USD","LU2097828557.USD","LU2125910849.SGD","LU0329678337.USD","BK1607","LU2293587155.HKD","03690","LU0072462343.USD","LU0345775950.USD","LU0327786744.USD","LU0029874905.USD","LU1048484197.HKD","LU1993786604.SGD","LU0359201612.USD","LU1366334578.USD","LU0449509016.USD","HK0000500386.USD","LU0762540952.USD","SG9999001051.SGD","LU0683595622.HKD","LU0048580855.USD","LU0348767384.USD","LU0819121731.USD","LU0287142896.SGD","SG9999009997.SGD","LU0214875030.USD","MPNGY","IE00B0JY6N72.USD","SG9999001226.SGD","BK1555","LU0577902538.SGD","LU0918141705.HKD","LU2543165471.USD","LU0043850808.USD","00960","SG9999002562.SGD","LU0235996351.USD","LU0882747503.HKD","09992","IE00BYV24P56.USD","81024","LU0345780281.USD","LU0708995153.HKD","LU1224444064.USD","LU0672654166.SGD","BK1521","LU1282649141.HKD","BK1507","SGXZ86797644.SGD","LU2087589342.USD","SG9999001903.USD","LU0164865239.USD","LU2148510915.USD","LU0011963245.USD","89988","LU0608807946.USD","LU1282649810.SGD","BK1505","LU1880383366.USD","LU2488822045.USD","IE00B29SXG58.USD","IE00BMCWC346.EUR","BK1618","LU0348816934.USD","IE00B031HY20.USD","LU1810669033.SGD","LU0211977185.USD","BK1233","LU0244354667.USD","LU0477156797.USD","BK1109","03145","LU1046422090.SGD","LU0702159699.USD","LU0164880469.USD","LU0359201885.HKD","LU0630378429.USD","BK1523","LU0630378692.HKD","LU1201861165.SGD","HK0000252160.HKD","IE00BWDBJ730.SGD","LU0163747925.USD","LU1880398554.USD","LU0561508036.HKD","SG9999001093.SGD","LU0516422952.EUR","03143","LU1969619763.USD","BK1506","BK1135","02009","LU0106259558.USD","LU1323998911.USD","01196","LU2097828805.USD","LU0531971595.HKD","LU0210526637.USD","IE0034224299.USD","LU2045819591.USD","BK1583","01336","LU0084288322.USD","BK1502","LU0898667661.SGD","LU0128522157.USD","LU0054237671.USD","LU0572944931.SGD","SG9999001689.USD","LU0823041008.USD","LU0048388663.USD","LU1720051017.SGD","00751","01349","LU0541502299.USD","IE00BZ08YT58.USD","IE00BVYPNP33.GBP","LU0165289439.USD","LU0197773673.USD","LU1366334651.USD","LU0181495838.USD","SGXZ62798434.SGD","BK1592","LU0054450605.USD","LU1152091168.USD","LU0345776255.USD","LU1481107354.HKD","BK1554","LU0823038988.USD","LU1655091459.SGD","IE00BGHQDM52.EUR","LU0642271901.SGD","GELYY","LU2242644610.SGD","LU0588545904.SGD","IE0008368742.USD","LU0516422440.USD","HK0000306685.HKD","BK1231","01070","IE00B031J352.USD","LU1868837722.USD","LU0130518102.USD","01347","LU0266512127.USD","LU0762542818.HKD","LU0648000940.SGD","BK1162","LU1044874839.SGD","SG9999004220.SGD","LU0049112450.USD","LU0886674414.USD","BK1095","LU0463099449.HKD","LU0130103400.USD","SG9999000459.SGD","LU0315179316.USD","LU1868838027.USD","LU2097828474.EUR","HK0000252152.HKD","IE0032431581.USD","BK1105","02828","BK1614","LU0791591158.USD","LU0106959298.USD","LU0082770016.SGD","IE00BMPRXN33.USD","LU1048596156.SGD","BK1503","LU0577902298.EUR","LU1880398471.USD","LU0314109678.HKD","SG9999010052.SGD","LU0449515922.USD","SG9999001069.SGD","BK1590","LU0315178854.USD","BK1237","HPAD.SI","LU0862451753.SGD","LU0737861699.HKD","00981","LU0708995583.HKD","LU2778985437.USD","IE00B19Z5X02.USD","01675","02648","LU0261947096.USD","01801","LU1102505762.USD","LU1316542783.SGD","SG9999002950.SGD","LU0348805143.USD","LU0823426308.USD","LU0254981946.USD","LU0096374516.USD","LU1166156734.SGD","BK1584","BK1124","LU0061477393.USD","LU0082770016.USD","LU0431992006.USD","601318","LU0531970944.HKD","LU0540923850.HKD","LU0880133367.SGD","LU0326948709.USD","SG9999012744.USD","LU0588545730.USD","BK1191","LU0456854461.SGD","BK1184","LU0359202008.SGD","LU0251144936.SGD","LU0890818403.SGD","LU2460026573.USD","LU1226287529.USD","SG9999000327.SGD","LU0607220059.USD","IE0008369823.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":16,"pageCount":3,"totalSize":312,"code":"91000000","status":"200"}]}}